These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 18229572)

  • 1. Bacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections.
    Braido F; Tarantini F; Ghiglione V; Melioli G; Canonica GW
    Int J Chron Obstruct Pulmon Dis; 2007; 2(3):335-45. PubMed ID: 18229572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Immunological Benefits of OM-85 Bacterial Lysate in Patients with Allergic Rhinitis, Asthma, and COPD and Recurrent Respiratory Infections.
    Koatz AM; Coe NA; Cicerán A; Alter AJ
    Lung; 2016 Aug; 194(4):687-97. PubMed ID: 27117798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sub-lingual administration of a polyvalent mechanical bacterial lysate (PMBL) in patients with moderate, severe, or very severe chronic obstructive pulmonary disease (COPD) according to the GOLD spirometric classification: A multicentre, double-blind, randomised, controlled, phase IV study (AIACE study: Advanced Immunological Approach in COPD Exacerbation).
    Braido F; Melioli G; Cazzola M; Fabbri L; Blasi F; Moretta L; Canonica GW;
    Pulm Pharmacol Ther; 2015 Aug; 33():75-80. PubMed ID: 25951945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review.
    Schaad UB
    World J Pediatr; 2010 Feb; 6(1):5-12. PubMed ID: 20143206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial immunostimulants--mechanism of action and clinical application in respiratory diseases.
    Rozy A; Chorostowska-Wynimko J
    Pneumonol Alergol Pol; 2008; 76(5):353-9. PubMed ID: 19003766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical analysis of the effect of OM-85 for the prevention of recurrent respiratory tract infections or wheezing/asthma from systematic reviews with meta-analysis.
    Castro-Rodriguez JA; Turi KN; Forno E
    Pediatr Allergy Immunol; 2024 Jul; 35(7):e14186. PubMed ID: 39016384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of OM-85 Given during Two Consecutive Years to Children with a History of Recurrent Respiratory Tract Infections: A Retrospective Study.
    Esposito S; Bianchini S; Polinori I; Principi N
    Int J Environ Res Public Health; 2019 Mar; 16(6):. PubMed ID: 30934539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of Broncho-Vaxom treatment on serum concentration of metalloproteinase-9 in patients with chronic obstructive pulmonary disease].
    Targowski T; Jahnz-Rózyk K; Płusa T; Niedziałkowski P; Rozyńska R
    Pol Merkur Lekarski; 2005 Nov; 19(113):630-3. PubMed ID: 16498799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of a bacterial extract against acute exacerbation in patients with chronic bronchitis accompanied by chronic obstructive pulmonary disease.
    Li J; Zheng JP; Yuan JP; Zeng GQ; Zhong NS; Lin CY
    Chin Med J (Engl); 2004 Jun; 117(6):828-34. PubMed ID: 15198881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoregulatory and immunostimulatory responses of bacterial lysates in respiratory infections and asthma.
    Kearney SC; Dziekiewicz M; Feleszko W
    Ann Allergy Asthma Immunol; 2015 May; 114(5):364-9. PubMed ID: 25752734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyvalent mechanical bacterial lysate for the prevention of recurrent respiratory infections: a meta-analysis.
    Cazzola M; Anapurapu S; Page CP
    Pulm Pharmacol Ther; 2012 Feb; 25(1):62-8. PubMed ID: 22155205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of OM-85 in Patients with Chronic Bronchitis and/or Chronic Obstructive Pulmonary Disease.
    Tang H; Fang Z; Saborío GP; Xiu Q
    Lung; 2015 Aug; 193(4):513-9. PubMed ID: 26044556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind study of OM-85 in patients with chronic bronchitis or mild chronic obstructive pulmonary disease.
    Solèr M; Mütterlein R; Cozma G;
    Respiration; 2007; 74(1):26-32. PubMed ID: 16772707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of OM-85 BV in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Pan L; Jiang XG; Guo J; Tian Y; Liu CT
    J Clin Pharmacol; 2015 Oct; 55(10):1086-92. PubMed ID: 25903441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of OM-85 BV in COPD and chronic bronchitis: a systematic review.
    Sprenkle MD; Niewoehner DE; MacDonald R; Rutks I; Wilt TJ
    COPD; 2005 Mar; 2(1):167-75. PubMed ID: 17136978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors for chronic obstructive pulmonary disease.
    Kikuchi S; Imai H; Tani Y; Tajiri T; Watanabe N
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013113. PubMed ID: 32844430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a polyvalent bacterial lysate in patients with recurrent respiratory tract infections: results of a prospective, placebo-controlled, randomized, double-blind study.
    Rutishauser M; Pitzke P; Grevers G; van Aubel A; Elsasser U; Kämmereit A
    Adv Ther; 1998; 15(6):330-41. PubMed ID: 10351117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial dysfunction, respiratory infections and asthma: the importance of immunomodulation. A focus on OM-85.
    Cardinale F; Lombardi E; Rossi O; Bagnasco D; Bellocchi A; Menzella F
    Expert Rev Respir Med; 2020 Oct; 14(10):1019-1026. PubMed ID: 32635771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The administration of a polyvalent mechanical bacterial lysate in elderly patients with COPD results in serological signs of an efficient immune response associated with a reduced number of acute episodes.
    Ricci R; Palmero C; Bazurro G; Riccio AM; Garelli V; Di Marco E; Cirillo C; Braido F; Canonica GW; Melioli G
    Pulm Pharmacol Ther; 2014 Feb; 27(1):109-13. PubMed ID: 23792312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of broncho-vaxom preparation in clinical practice].
    Mierzejewska-Zawisza MJ; Jahnz-Rózyk K; Rabczuk J
    Pol Merkur Lekarski; 2003 May; 14(83):457-8. PubMed ID: 12939827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.